Status:
COMPLETED
Physiological Flow of Liquids in Head and Neck Cancer Patients: A Pilot Study
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions:
Deglutition Disorders
Oropharynx Cancer
Eligibility:
All Genders
18-100 years
Brief Summary
This study is part of a larger grant, for which the overall goal is to collect measurements of liquid flow through the oropharynx (i.e., mouth and throat) during swallowing. The focus of this study is...
Detailed Description
Thickened liquids are commonly used as an intervention for dysphagia (swallowing impairment). However, the field lacks a clear understanding of how liquids of different consistencies behave during swa...
Eligibility Criteria
Inclusion
- An initial cancer diagnosis of cancer in the base of tongue region of the oropharynx (Tumor staging T2,T3 \& T4; Nodal staging N0 orN1; Human Papilloma Virus + or -).
- Completion of bilateral radiation therapy to the neck 3 months prior to enrollment
- No longer requiring primary enteral feeding for nutrition.
Exclusion
- Prior history of swallowing, motor speech, gastro#esophageal difficulties, chronic sinusitis or taste disturbance.
- Previous radiation to the head and neck (prior to current illness);
- Previous cancer diagnosis;
- Prior or planned neck dissection;
- Trachestomy in situ;
- Neurological difficulties unrelated to spinal disorder (e.g. Stroke, Parkinson disease, etc).
- Cognitive communication difficulties that may hinder ability to participate.
- Current use of mechanical ventilation
- Type 1 Diabetes (due to the requirement to swallow stimuli containing starch based thickeners, which carry a significant carbohydrate load).
- Known allergies to latex, food coloring or dental glue (due to the probability that these items will come into contact with the oral mucosa during data collection).
- Occupational exposure to radiation exceeding 10 mSv in the past 6 months.
- Current pregnancy.
Key Trial Info
Start Date :
December 19 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2021
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04112940
Start Date
December 19 2016
End Date
March 30 2021
Last Update
April 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network
Toronto, Ontario, Canada, M5G 2C4